Kenneth Kovan - Net Worth and Insider Trading
Kenneth Kovan Net Worth
The estimated net worth of Kenneth Kovan is at least $463,367 dollars as of 2024-09-20. Kenneth Kovan is the Senior Officer of BioVaxys Technology Corp and owns about 6,619,529 shares of BioVaxys Technology Corp (XCNQ:BIOV) stock worth over $463,367. Details can be seen in Kenneth Kovan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Kenneth Kovan has not made any transactions after 2023-07-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Kenneth Kovan
Kenneth Kovan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Kenneth Kovan owns 1 companies in total, including BioVaxys Technology Corp (XCNQ:BIOV) .
Click here to see the complete history of Kenneth Kovan’s form 4 insider trades.
Insider Ownership Summary of Kenneth Kovan
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| XCNQ:BIOV | BioVaxys Technology Corp | 2023-07-14 | Senior Officer |
Kenneth Kovan Latest Holdings Summary
Kenneth Kovan currently owns a total of 1 stock. Kenneth Kovan owns 6,619,529 shares of BioVaxys Technology Corp (XCNQ:BIOV) as of July 14, 2023, with a value of $463,367.
Latest Holdings of Kenneth Kovan
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| XCNQ:BIOV | BioVaxys Technology Corp | 2023-07-14 | 6,619,529 | 0.07 | 463,367 |
Holding Weightings of Kenneth Kovan
Kenneth Kovan Form 4 Trading Tracker
According to the SEC Form 4 filings, Kenneth Kovan has made a total of 2 transactions in BioVaxys Technology Corp (XCNQ:BIOV) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in BioVaxys Technology Corp is the acquisition of 150,000 shares on July 14, 2023, which cost Kenneth Kovan around $3,670.
Insider Trading History of Kenneth Kovan
- 1
Kenneth Kovan Trading Performance
GuruFocus tracks the stock performance after each of Kenneth Kovan's buying transactions within different timeframes. To be detailed, the average return of stocks after 1 year bought by Kenneth Kovan is 180%. GuruFocus also compares Kenneth Kovan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Kenneth Kovan within 1 year outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Kenneth Kovan's insider trading performs compared to the benchmark.
Performance of Kenneth Kovan
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -40 | | | | | |
| Relative Return to S&P 500(%) | -39.65 | | | | | |
Kenneth Kovan Ownership Network
Kenneth Kovan Owned Company Details
What does BioVaxys Technology Corp do?
Who are the key executives at BioVaxys Technology Corp?
Kenneth Kovan is the Senior Officer of BioVaxys Technology Corp. Other key executives at BioVaxys Technology Corp include and Director & Senior Officer James Passin .
BioVaxys Technology Corp (XCNQ:BIOV) Insider Trades Summary
Over the past 18 months, Kenneth Kovan made 2 insider transaction in BioVaxys Technology Corp (XCNQ:BIOV) with a net purchase of 250,000. Other recent insider transactions involving BioVaxys Technology Corp (XCNQ:BIOV) include a net sale of 5,000,000 shares made by James Passin ,
In summary, during the past 3 months, insiders sold 5,000,000 shares of BioVaxys Technology Corp (XCNQ:BIOV) in total and bought 0 shares, with a net sale of 5,000,000 shares. During the past 18 months, 5,000,000 shares of BioVaxys Technology Corp (XCNQ:BIOV) were sold and 250,000 shares were bought by its insiders, resulting in a net sale of 4,750,000 shares.
BioVaxys Technology Corp (XCNQ:BIOV)'s detailed insider trading history can be found in Insider Trading Tracker table.
BioVaxys Technology Corp Insider Transactions
Kenneth Kovan Mailing Address
Above is the net worth, insider trading, and ownership report for Kenneth Kovan. Currently GuruFocus does not have mailing address information for Kenneth Kovan.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
